Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing-Reference-Cited by-同舟云学术

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

Published:2012-07 Issue:6 Volume:12 Page:593-602
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Ong Frank S,Das Kingshuk,Wang Jay,Vakil Hana,Kuo Jane Z,Blackwell Wendell-Lamar B,Lim Stephen W,Goodarzi Mark O,Bernstein Kenneth E,Rotter Jerome I,Grody Wayne W

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1586/erm.12.59

Reference84 articles.

1. Emerging companion diagnostics for cancer drugs

2. The cell cycle and cancer

3. Gene expression profiling in breast cancer: classification, prognostication, and prediction

4. Integrating biomarkers in clinical trials

5. Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of brush and mushroom conformations in biomedical applications;Chemical Papers;2024-07-19

2. Biologics, theranostics, and personalized medicine in drug delivery systems;Pharmacological Research;2024-03

3. Current Trends in the Biomarker'sDiscovery for the Treatment and Management of Colorectal Cancer: A ComprehensiveReview;Current Medicinal Chemistry;2024-01-31

4. Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review;Molecular Biology Reports;2024-01-22

5. Harnessing Healing Power: A Comprehensive Review on Platelet-Rich Plasma in Compound Fracture Care;Cureus;2024-01-22